Template:Acute cystitis antibiotics: Difference between revisions
No edit summary |
|||
| Line 1: | Line 1: | ||
===Women, Uncomplicated | ===Outpatient=== | ||
'''Women, Uncomplicated''' | |||
*[[Nitrofurantoin]] ER 100mg BID x 5d, OR | *[[Nitrofurantoin]] ER 100mg BID x 5d, OR | ||
*[[TMP/SMX]] DS (160/800mg) 1 tab BID x 3d, OR | *[[TMP/SMX]] DS (160/800mg) 1 tab BID x 3d, OR | ||
| Line 5: | Line 6: | ||
*[[Ciprofloxacin]] 250mg BID x3d | *[[Ciprofloxacin]] 250mg BID x3d | ||
'''Women, Complicated''' | |||
*[[Ciprofloxacin]] 500mg BID x10-14d, OR | *[[Ciprofloxacin]] 500mg BID x10-14d, OR | ||
*[[Cefpodoxime]] 200 mg BID x10-14d | *[[Cefpodoxime]] 200 mg BID x10-14d | ||
'''Women, Concern for [[Urethritis]]''' | |||
*[[Ceftriaxone]] 250mg IM x1 AND [[azithromycin]] 1gm PO x1 AND [[nitrofurantoin]] ER 100mg BID x5d, OR | *[[Ceftriaxone]] 250mg IM x1 AND [[azithromycin]] 1gm PO x1 AND [[nitrofurantoin]] ER 100mg BID x5d, OR | ||
*[[Levofloxacin]] 500mg QD x 14d (covers urinary pathogens, [[GC]], and [[chlamydia]]) | *[[Levofloxacin]] 500mg QD x 14d (covers urinary pathogens, [[GC]], and [[chlamydia]]) | ||
**[[GC]] resistance to fluoroquinolones is increasing | **[[GC]] resistance to fluoroquinolones is increasing | ||
'''Men''' | |||
*[[Ciprofloxacin]] 500mg BID x10-14d OR | *[[Ciprofloxacin]] 500mg BID x10-14d, OR | ||
*[[Cefpodoxime]] 200 mg BID x10-14d | *[[Cefpodoxime]] 200 mg BID x10-14d | ||
===Inpatient Options=== | ===Inpatient Options=== | ||
*[[Ciprofloxacin]] 400mg IV q12hr OR | *[[Ciprofloxacin]] 400mg IV q12hr, OR | ||
*[[Ceftriaxone]] 1gm IV QD OR | *[[Ceftriaxone]] 1gm IV QD, OR | ||
*Cefotaxime 1-2gm IV q8hr OR | *Cefotaxime 1-2gm IV q8hr, OR | ||
*[[Gentamicin]] 3mg/kg/day divided q8hr +/- ampicillin 1–2 gm q4hr OR | *[[Gentamicin]] 3mg/kg/day divided q8hr +/- ampicillin 1–2 gm q4hr, OR | ||
*[[Piperacillin/Tazobactam]] 3.375 gm IV q6hr OR | *[[Piperacillin/Tazobactam]] 3.375 gm IV q6hr, OR | ||
*[[Cefepime]] 2gm IV q8hr OR | *[[Cefepime]] 2gm IV q8hr, OR | ||
*[[Imipenem]] 500mg IV q8hr | *[[Imipenem]] 500mg IV q8hr | ||
Revision as of 21:19, 22 February 2015
Outpatient
Women, Uncomplicated
- Nitrofurantoin ER 100mg BID x 5d, OR
- TMP/SMX DS (160/800mg) 1 tab BID x 3d, OR
- Cephalexin 250mg QID x 5d, OR
- Ciprofloxacin 250mg BID x3d
Women, Complicated
- Ciprofloxacin 500mg BID x10-14d, OR
- Cefpodoxime 200 mg BID x10-14d
Women, Concern for Urethritis
- Ceftriaxone 250mg IM x1 AND azithromycin 1gm PO x1 AND nitrofurantoin ER 100mg BID x5d, OR
- Levofloxacin 500mg QD x 14d (covers urinary pathogens, GC, and chlamydia)
- GC resistance to fluoroquinolones is increasing
Men
- Ciprofloxacin 500mg BID x10-14d, OR
- Cefpodoxime 200 mg BID x10-14d
Inpatient Options
- Ciprofloxacin 400mg IV q12hr, OR
- Ceftriaxone 1gm IV QD, OR
- Cefotaxime 1-2gm IV q8hr, OR
- Gentamicin 3mg/kg/day divided q8hr +/- ampicillin 1–2 gm q4hr, OR
- Piperacillin/Tazobactam 3.375 gm IV q6hr, OR
- Cefepime 2gm IV q8hr, OR
- Imipenem 500mg IV q8hr